SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NexStar Pharm(NXTR)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
328 5 0 NXTR
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
178 mz, Thanks for the extensive preview of coming attractions. I couldn't fiCzechsinthemail-8/27/1997
177 Baird: I agree with you view regards the DepoCyte. On DepoAmikacin, because I Miljenko Zuanic-8/27/1997
176 mz, Here is what DEPO's Mid-Year Report says about DepoAmikacin: <i>Czechsinthemail-8/27/1997
175 Baird: >>BTW, Do you have particular reason to believe DepoAmikacin has Miljenko Zuanic-8/26/1997
174 Miljenko, Thanks for your response. My overall opinion of NXTR is generally fCzechsinthemail-8/26/1997
173 Baird: Repost speak for itself. I didn't look in detail what will be potenMiljenko Zuanic-8/25/1997
172 Miljenko, Here is a repost of information from Nexstar's 10/2/96 release oCzechsinthemail-8/25/1997
171 Juck: Best will be to ask them for explanation or order full report. Yes, I dMiljenko Zuanic-8/19/1997
170 >>. . .analyst decrease estimate for NXTR Q's earnings, also probablyjwk-8/18/1997
169 Jack: >> Perhaps some funds will be more interested now with the FDA'Miljenko Zuanic-8/18/1997
168 >> I wrote in my many previous posts about your question. << MZ, jwk-8/14/1997
167 Per Today's (August 13, 1997) Wall Street Journal, NXTR is going to take $1Steven Yang-8/13/1997
166 Jack, I wrote in my many previous posts about your question. You will have to Miljenko Zuanic-8/13/1997
165 Nice to see some strength so far on the opening. Perhaps the sag yesterday aftjwk-8/13/1997
164 Jack, Daug, and others: Two good and important news in 24 hr. How can we expecMiljenko Zuanic-8/12/1997
163 I there a downside to any of this news, or is this what market has been waitingjwk-8/12/1997
162 FDA approval too nexstar.comDoug Markle-8/12/1997
161 When and how will we find these details out? Do we just have to watch "majwk-8/12/1997
160 Bill: Agree. Only I do not know are there royalty fee or cross-license fee, paMiljenko Zuanic-8/12/1997
159 Miljenko, interesting that the news release did not specify the royalties that WWS-8/11/1997
158 To all: LIPO litigation is over! businesswire.com LIPO will not stop AmBisomMiljenko Zuanic-8/11/1997
157 To all: When I answered question on my math calculation for the future AmBisomMiljenko Zuanic-8/10/1997
156 Wednesday August 6 12:59 PM EDT Company Press Release South Korea Approves Ajwk-8/6/1997
155 Russia Approves AmBisome and DaunoXome , 12:29, Aug 4 biz.yahoo.comTerry Jackson-8/4/1997
154 Bill, What would (will) you do different than NXTR managers for last year(todMiljenko Zuanic-7/30/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News